Aptinyx (APTX) News and press releases

12 Health Care Stocks Moving In Friday's Intraday Session

5 May 23

Movers

Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

5 May 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers

Stocks That Hit 52-Week Lows On Friday

31 Mar 23

Options

On Friday, 93 stocks made new 52-week lows.

Aptinyx Evaluates Strategic Alternatives For Its Future After Failed Trials, 60% Layoffs

31 Mar 23

Biotech, News, Penny Stocks, Health Care, General

Aptinyx Q4 EPS $(0.18) Beats $(0.19) Estimate

30 Mar 23

Earnings, News

Aptinyx (NASDAQ:APTX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 37.93 percent increase over losses of $(0.29) per share from the same

12 Health Care Stocks Moving In Friday's Intraday Session

24 Mar 23

Movers

Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

24 Mar 23

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring.

Aptinyx Granted European Patent Titled 'Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders)'

23 Mar 23

News, FDA

https://data.epo.org/publication-server/pdf-document?pn=3490992&ki=B1&cc=EP

Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives

30 Mar 23

Press Releases

Aptinyx Inc. (NASDAQ:APTX) today reported recent business updates and financial results for the fourth quarter and full year 2022. Recent Business Updates In March, Aptinyx completed an analysis of the data from the